by Dennis Crouch
The Federal Circuit’s pending en banc review in EcoFactor v. Google is heating up, to address fundamental questions about the reliability standards for expert damages testimony in patent cases. The case highlights growing tensions betw…
by Dennis Crouch
With Donald Trump’s reelection, leaders within the Biden administration will be stepping down over the next two months. USPTO Director Kathi Vidal has announced her departure from the agency, effective in December 2024. Deputy Di…
by Dennis Crouch
With Donald Trump’s reelection, leaders within the Biden administration will be stepping down over the next two months. USPTO Director Kathi Vidal has announced her departure from the agency, effective in December 2024. Deputy Di…
by Dennis Crouch
Patent law cases continue to be brought to the Supreme Court’s attention, even though the court has not granted certiorari in any patent case for some time. Twelve potential cases have documents on file with the court. Currently, eigh…
by Dennis Crouch
Patent law cases continue to be brought to the Supreme Court’s attention, even though the court has not granted certiorari in any patent case for some time. Twelve potential cases have documents on file with the court. Currently, eigh…
by Dennis Crouch
I’m excited to share a new article I recently published examining the relationship between intellectual property rights and artificial intelligence regulation, recently published in Volume 89, Issue 3 of the Missouri Law Review. …
by Dennis Crouch
The Supreme Court currently has before it a unique opportunity to address a longstanding problem with the Federal Circuit’s practice of issuing no-opinion summary affirmances in patent cases. The recently filed ParkerVision petit…
by Dennis Crouch
The Supreme Court currently has before it a unique opportunity to address a longstanding problem with the Federal Circuit’s practice of issuing no-opinion summary affirmances in patent cases. The recently filed ParkerVision petit…
by Dennis Crouch
Today at 2pm Eastern, the Federal Circuit will hear arguments in a case that could significantly shape pharmaceutical patent listing practices under the Hatch-Waxman Act. In Teva v. Amneal (No. 24-1936), the court will consider whether…
I previously wrote about the Federal Circuit’s FRAND international injunction decision in Ericsson v. Lenovo, but also invited Prof. Jorge Contreras to provide his insight. Contreras is one of the world’s leading experts on FRAND litigatio…
